Vitrolife AB (ST:VITR) — Market Cap & Net Worth
Market Cap & Net Worth: Vitrolife AB (VITR)
Vitrolife AB (ST:VITR) has a market capitalization of $1.53 Billion (Skr14.18 Billion) as of May 3, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #7317 globally and #104 in its home market, demonstrating a -1.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vitrolife AB's stock price Skr104.70 by its total outstanding shares 135447190 (135.45 Million). Analyse Vitrolife AB cash flow conversion to see how efficiently the company converts income to cash.
Vitrolife AB Market Cap History: 2015 to 2026
Vitrolife AB's market capitalization history from 2015 to 2026. Data shows growth from $805.45 Million to $1.53 Billion (10.94% CAGR).
Vitrolife AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vitrolife AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.58x
Vitrolife AB's market cap is 0.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.09 Billion | $856.11 Million | $190.37 Million | 1.27x | 5.71x |
| 2017 | $1.76 Billion | $1.05 Billion | $263.64 Million | 1.68x | 6.67x |
| 2018 | $2.09 Billion | $1.15 Billion | $309.70 Million | 1.81x | 6.74x |
| 2019 | $2.82 Billion | $1.48 Billion | $382.79 Million | 1.90x | 7.36x |
| 2020 | $3.10 Billion | $1.25 Billion | $286.85 Million | 2.49x | 10.79x |
| 2021 | $8.06 Billion | $1.68 Billion | $341.00 Million | 4.79x | 23.62x |
| 2022 | $2.69 Billion | $3.23 Billion | $394.00 Million | 0.83x | 6.82x |
| 2023 | $2.82 Billion | $3.51 Billion | -$3.85 Billion | 0.80x | N/A |
| 2024 | $3.13 Billion | $3.61 Billion | $513.00 Million | 0.87x | 6.11x |
| 2025 | $2.00 Billion | $3.44 Billion | -$5.01 Billion | 0.58x | N/A |
Competitor Companies of VITR by Market Capitalization
Companies near Vitrolife AB in the global market cap rankings as of May 3, 2026.
Key companies related to Vitrolife AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Vitrolife AB Historical Marketcap From 2015 to 2026
Between 2015 and today, Vitrolife AB's market cap moved from $805.45 Million to $ 1.53 Billion, with a yearly change of 10.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr1.53 Billion | -23.58% |
| 2025 | Skr2.00 Billion | -36.28% |
| 2024 | Skr3.13 Billion | +11.13% |
| 2023 | Skr2.82 Billion | +4.96% |
| 2022 | Skr2.69 Billion | -66.64% |
| 2021 | Skr8.06 Billion | +160.16% |
| 2020 | Skr3.10 Billion | +9.93% |
| 2019 | Skr2.82 Billion | +34.93% |
| 2018 | Skr2.09 Billion | +18.66% |
| 2017 | Skr1.76 Billion | +61.81% |
| 2016 | Skr1.09 Billion | +34.98% |
| 2015 | Skr805.45 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Vitrolife AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.53 Billion USD |
| MoneyControl | $1.53 Billion USD |
| MarketWatch | $1.53 Billion USD |
| marketcap.company | $1.53 Billion USD |
| Reuters | $1.53 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more